Baird analyst Robert Mason maintains Novanta (NASDAQ:NOVT) with a Neutral and raises the price target from $170 to $175.
Baird Maintains Neutral on Novanta, Raises Price Target to $175
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.